CAS 533902-29-3

LCKLSL

Fórmula: C₃₀H₅₇N₇O₈S

InChI: InChI=1S/C30H57N7O8S/c1-16(2)11-19(32)25(39)37-24(15-46)29(43)33-20(9-7-8-10-31)26(40)34-21(12-17(3)4)27(41)36-23(14-38)28(42)35-22(30(44)45)13-18(5)6/h16-24,38,46H,7-15,31-32H2,1-6H3,(H,33,43)(H,34,40)(H,35,42)(H,36,41)(H,37,39)(H,44,45)/t19-,20-,21-,22-,23-,24-/m0/s1

Chave InChI: HTBYABHLBWELKC-BTNSXGMBSA-N

SMILES: CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)N

Sinónimos:

• LCKLSL

LCKLSL

CAS: 533902-29-3

LCKLSL, an N-terminal hexapeptide, inhibits AnxA2 and tPA binding, reduces plasmin, and exhibits anti-angiogenic effects.

Fórmula: C₃₀H₅₇N₇O₈S

Cor e Forma: Solid

Peso molecular: 675.89

Ref: TM-T40614